(Q81077914)

English

Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases

scientific article published on 08 August 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

based on heuristic

inferred from title

pneumococcal infection

1 reference

based on heuristic

inferred from title

author name string

Honar Cherif

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Ola Landgren

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Helle B Konradsen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Mats Kalin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Magnus Björkholm

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

8 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

75-81

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Splenic studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Polyvalent Pneumococcal-Polysaccharide Immunization of Patients with Sickle-Cell Anemia and Patients with Splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Splenectomy and serious infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Efficacy and safety of pneumococcal revaccination after splenectomy for trauma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Risk of infection and death among post-splenectomy patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Recurrence of pneumonia in relation to the antibody response after pneumococcal vaccination in middle-aged and elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Treatment of Hodgkin's disease: the Swedish National Care Programme experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

T-cell-rich B-cell lymphoma - diagnostic and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Phase II study of cyclophosphamide, interferon-alpha and betamethasone (CIB) as induction therapy for patients 60-75 years of age with multiple myeloma stages II and III.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

The value of laparotomy and splenectomy in the staging of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Impaired antibody response to pneumococcal capsular polysaccharides and phosphorylcholine in adult patients with a history of bacteremic pneumococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Antibody response to pneumococcal vaccine in patients with solid tumors and lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Pneumococcal vaccination: current and future issues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Should the new pneumococcal vaccine be used in high-risk children?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Antibiotic prevention of pneumococcal infections in asplenic hosts: admission of insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Overwhelming postsplenectomy infection in a patient with penicillin-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody response to pneumococcal vaccination in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.07.054

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107293%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81077914&oldid=2111443340"